These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30607326)

  • 61. Performance profiling: a role for sport science in the fight against doping?
    Schumacher YO; Pottgiesser T
    Int J Sports Physiol Perform; 2009 Mar; 4(1):129-33. PubMed ID: 19417234
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Doping in sport and exercise: anabolic, ergogenic, health and clinical issues.
    Bird SR; Goebel C; Burke LM; Greaves RF
    Ann Clin Biochem; 2016 Mar; 53(Pt 2):196-221. PubMed ID: 26384361
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Doping and athletes--prevention and counseling.
    Oseid S
    J Allergy Clin Immunol; 1984 May; 73(5 Pt 2):735-9. PubMed ID: 6715738
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Epidemiologic approach of doping in sport. A review.
    Laure P
    J Sports Med Phys Fitness; 1997 Sep; 37(3):218-24. PubMed ID: 9407754
    [TBL] [Abstract][Full Text] [Related]  

  • 65. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes.
    Deligiannis A; Björnstad H; Carre F; Heidbüchel H; Kouidi E; Panhuyzen-Goedkoop NM; Pigozzi F; Schänzer W; Vanhees L;
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):687-94. PubMed ID: 17001206
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The future of doping control in athletes. Issues related to blood sampling.
    Birkeland KI; Hemmersbach P
    Sports Med; 1999 Jul; 28(1):25-33. PubMed ID: 10461710
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Facilitators and barriers in preventing doping among recreational athletes: A qualitative interview study among police officers.
    Kvillemo P; Strandberg AK; Elgán TH; Gripenberg J
    Front Public Health; 2022; 10():1017801. PubMed ID: 36276382
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Doping. High-tech cheating in sport].
    Striegel H; Simon P
    Internist (Berl); 2007 Jul; 48(7):737-42. PubMed ID: 17426943
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Performance-enhancing drugs and the Olympics.
    Watson CJ; Stone GL; Overbeek DL; Chiba T; Burns MM
    J Intern Med; 2022 Feb; 291(2):181-196. PubMed ID: 35007384
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The use of prohibited substances for therapeutic reasons in athletes affected by endocrine diseases and disorders: the therapeutic use exemption (TUE) in clinical endocrinology.
    Di Luigi L; Pigozzi F; Sgrò P; Frati L; Di Gianfrancesco A; Cappa M
    J Endocrinol Invest; 2020 May; 43(5):563-573. PubMed ID: 31734891
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Medicine and science in the fight against doping in sport.
    Catlin DH; Fitch KD; Ljungqvist A
    J Intern Med; 2008 Aug; 264(2):99-114. PubMed ID: 18702750
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A Behaviourally Informed Approach to Reducing the Risk of Inadvertent Anti-doping Rule Violations from Supplement Use.
    Backhouse SH
    Sports Med; 2023 Dec; 53(Suppl 1):67-84. PubMed ID: 37801267
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Detection of anabolic androgenic steroid use by elite athletes and by members of the general public.
    Anawalt BD
    Mol Cell Endocrinol; 2018 Mar; 464():21-27. PubMed ID: 28943276
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Doping--also a problem in general practice?].
    Dickhuth HH; Berg A; Baumstark M; Rokitzki L; Huonker M; Keul J
    Fortschr Med; 1989 Sep; 107(28):585-8. PubMed ID: 2613151
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mass spectrometry in sports drug testing-Analytical approaches and the athletes' exposome.
    Thevis M; Görgens C; Guddat S; Thomas A; Geyer H
    Scand J Med Sci Sports; 2024 Jan; 34(1):e14228. PubMed ID: 36539355
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The presence of doping agents in dietary supplements: A glimpse into the Brazilian situation.
    Torres CL; de Oliveira FAG; Jooris LF; Padilha MC; Pereira HMG
    Drug Test Anal; 2024 Jan; 16(1):38-48. PubMed ID: 37161689
    [TBL] [Abstract][Full Text] [Related]  

  • 77. ["Enjoy the Sport - Schools against doping and drug dependence": a health education intervention in secondary schools].
    Masala D; D'Egidio V; Iona T; La Torre G
    Ig Sanita Pubbl; 2019; 75(4):271-282. PubMed ID: 31887733
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A Moral Foundation for Anti-Doping: How Far Have We Progressed? Where Are the Limits?
    Murray TH
    Med Sport Sci; 2017; 62():186-193. PubMed ID: 28571014
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Australian athletes' knowledge of the WADA Prohibited Substances List and performance enhancing substances.
    Orr R; Grassmayr M; Macniven R; Grunseit A; Halaki M; Bauman A
    Int J Drug Policy; 2018 Jun; 56():40-45. PubMed ID: 29550541
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The World Anti-Doping Code 2003--consequences for physicians associated with elite athletes.
    Striegel H; Rössner D; Simon P; Niess AM
    Int J Sports Med; 2005 Apr; 26(3):238-43. PubMed ID: 15776342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.